NASDAQ · Biotechnology
Biocardia Inc (BCDA)
$0.79
+1.61%
34
In band
Moving averages
SMA 200$1.06-25.94%
Company profile
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. The company is headquartered in San Carlos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$13.95M
P/E ratioNone
EPS$-0.64
Beta0.654
Dividend yield0.00%
52-week high$1.50
52-week low$0.66
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
KTTA
Pasithea Therapeutics Corp
RSI 53
PHIO
Phio Pharmaceuticals Corp
RSI 28
GOVX
Geovax Labs Inc
RSI 17
SNGX
Soligenix Inc
RSI 21
BYSI
BeyondSpring Inc
RSI 37
BCTX
BriaCell Therapeutics Corp - New
RSI 44
RSI alerts for BCDA
An email when BCDA closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 5:13 AM EST